Cargando…
Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?
AIDS first emerged decades ago; however, its cure, i.e., eliminating all virus sources, is still unachievable. A critical burden of AIDS therapy is the evasive nature of HIV-1 in face of host immune responses, the so-called “latency.” Recently, a promising approach, the “Shock and Kill” strategy, wa...
Autores principales: | Salahong, Thanarat, Schwartz, Christian, Sungthong, Rungroch |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228869/ https://www.ncbi.nlm.nih.gov/pubmed/34072421 http://dx.doi.org/10.3390/v13061026 |
Ejemplares similares
-
BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
por: Lu, Panpan, et al.
Publicado: (2017) -
A new BET on the control of HIV latency
por: Karn, Jonathan
Publicado: (2013) -
Herbicide-tolerant endophytic bacteria of rice plants as the biopriming agents for fertility recovery and disease suppression of unhealthy rice seeds
por: Rangjaroen, Chakrapong, et al.
Publicado: (2019) -
Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
por: Stoszko, Mateusz, et al.
Publicado: (2015) -
Seed phytochemicals shape the community structures of cultivable actinobacteria‐inhabiting plant interiors of Thai pigmented rice
por: Nakaew, Nareeluk, et al.
Publicado: (2018)